Browse Canadian-specific press releases here.
\nPlease visit our Global website for access to global press releases dating back to 2009.
","categories":{"canada":"Canada"},"enabledFilters":["dateRange","category","text"],"captions":{"showMore":"Show more","mostRecent":"Most recent","mostRelevant":"Most relevant","search":"Search","download":"Download","resetSearch":"Reset search","clear":"Clear all","noResults":"We’re sorry, we can’t seem to find any search results matching your criteria.","resultsAvailable":null,"cancel":"Cancel","apply":"Apply","nowPlaying":null,"paginationAriaLabel":"Pagination","previous":"","previousAriaLabel":"Go to previous page","next":"next","nextAriaLabel":"Go to next page","goToPageAriaLabel":"Go to page ##PAGE##","currentPageAriaLabel":"Page","numberOfResultsPerPage":"Number of results per page","playVideo":"Play video {title}","filterBy":"Filter By:","sortBy":"Sort By:","select":"Select","category":"Category","dateRange":"Select date range","dateRangeBubbleText":"Date range","all":"All","lastWeek":"Last week","lastMonth":"Last month","lastSix":"Last 6 months","searchPrompt":"Enter a search term...","resultsText":"{filteredCount} out of {totalCount} results\n","tabbedArchivedSearchLabel":"","tabbedSearchBarLatestLabel":"","tabbedLatestTabDescription":"","tabbedVersionArchivedDescription":""},"counts":{"totalFound":95,"totalPages":5,"currentPage":1,"pageSize":20},"endpoint":"/api/search/pressreleases?parentId=6373&culture=en-CA","minimumSearchDate":null,"results":[{"headline":"GSK Canada secures priority review for regulatory submission of bepirovirsen, a potential functional cure treatment for chronic hepatitis B","description":"GSK today announced that it has filed a new drug submission for bepirovirsen for regulatory review in Canada","url":"/en-ca/media/press-releases/gsk-canada-secures-priority-review-for-regulatory-submission-of-bepirovirsen-a-potential-functional-cure-treatment-for-chronic-hepatitis-b/","datePublished":"April 30 2026","dateTime":"2026-04-30T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK enters agreement to acquire 35Pharma Inc.","description":"GSK plc (LSE/NYSE: GSK) today announced that it has entered an agreement to acquire 35Pharma Inc.","url":"/en-ca/media/press-releases/gsk-enters-agreement-to-acquire-35pharma-inc/","datePublished":"February 25 2026","dateTime":"2026-02-25T09:30:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"Survey finds majority of older Canadians with chronic illnesses unaware of increased shingles risk","description":"In Canada, shingles affects an estimated 130,000 individuals each year and approximately 1 in 3 adults will experience","url":"/en-ca/media/press-releases/survey-finds-majority-of-older-canadians-with-chronic-illnesses-unaware-of-increased-shingles-risk/","datePublished":"February 23 2026","dateTime":"2026-02-23T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer","description":"GSK announced today that Québec has become the first Canadian province to publicly reimburse Jemperli (dostarlimab for injection)","url":"/en-ca/media/press-releases/quebec-first-province-to-publicly-reimburse-jemperli-dostarlimab-for-injection-plus-chemotherapy-via-ramq-for-the-treatment-of-all-adult-patients-with-primary-advanced-or-first-recurrent-endometrial-cancer/","datePublished":"February 03 2026","dateTime":"2026-02-03T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for JEMPERLI plus chemotherapy for all adult patients with primary advanced or first recurrent endometrial cancer","description":"GSK is pleased to announce it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for Jemperli","url":"/en-ca/media/press-releases/gsk-and-the-pan-canadian-pharmaceutical-alliance-pcpa-successfully-finalize-negotiations-for-jemperli-plus-chemotherapy-for-all-adult-patients-with-primary-advanced-or-first-recurrent-endometrial-cancer/","datePublished":"December 04 2025","dateTime":"2025-12-04T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"Quebec becomes the first province to publicly reimburse Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anemia","description":"Quebec becomes the first province to publicly reimburse Ojjaara","url":"/en-ca/media/press-releases/quebec-becomes-the-first-province-to-publicly-reimburse-ojjaara-for-the-treatment-of-myelofibrosis-in-adults-who-have-moderate-to-severe-anemia/","datePublished":"November 13 2025","dateTime":"2025-11-13T09:30:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK Survey Highlights Gaps in RSV Awareness, Risk Understanding Among Vulnerable Older Canadian Adults","description":"Data from a new GSK survey released today highlight a potential blind spot in Respiratory Syncytial Virus (RSV) awareness ","url":"/en-ca/media/press-releases/gsk-survey-highlights-gaps-in-rsv-awareness-risk-understanding-among-vulnerable-older-canadian-adults/","datePublished":"November 05 2025","dateTime":"2025-11-05T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"New study highlights concerning link between heart disease and shingles risk","description":"New study highlights concerning link between heart disease and shingles risk","url":"/en-ca/media/press-releases/new-study-highlights-concerning-link-between-heart-disease-and-shingles-risk/","datePublished":"October 23 2025","dateTime":"2025-10-23T09:30:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK’s $300,000 Investment Fuels Launch of Innovative Lung Wellness Clinic to Transform Respiratory Care in Nova Scotia","description":"GSK’s $300,000 Investment Fuels Launch of Innovative Lung Wellness Clinic to Transform Respiratory Care in Nova Scotia","url":"/en-ca/media/press-releases/gsk-s-300-000-investment-fuels-launch-of-innovative-lung-wellness-clinic-to-transform-respiratory-care-in-nova-scotia/","datePublished":"October 21 2025","dateTime":"2025-10-21T13:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK and the pan-Canadian Pharmaceutical Alliance (pCPA) agree to a letter of intent (LOI) for Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anemia","description":"GSK today announced that it successfully entered into a letter of intent (LOI) with the with the pan-Canadian Pharmaceutical Alliance (pCPA)","url":"/en-ca/media/press-releases/gsk-and-the-pan-canadian-pharmaceutical-alliance-pcpa-agree-to-a-letter-of-intent-loi-for-ojjaara-for-the-treatment-of-myelofibrosis-in-adults-who-have-moderate-to-severe-anemia/","datePublished":"September 23 2025","dateTime":"2025-09-23T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"New Study Highlights Urgent Need for RSV Prevention in Older Adults","description":"New research presented this week at the Canadian Association for Population Therapeutics (CAPT-ACTP) Congress ","url":"/en-ca/media/press-releases/new-study-highlights-urgent-need-for-rsv-prevention-in-older-adults/","datePublished":"September 23 2025","dateTime":"2025-09-23T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK’s RSV Vaccine Arexvy Included in Publicly Funded Prevention Programs for Older Adults in Canada","description":"GSK announced today that Arexvy (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) ","url":"/en-ca/media/press-releases/gsk-s-rsv-vaccine-arexvy-included-in-publicly-funded-prevention-programs-for-older-adults-in-canada/","datePublished":"September 09 2025","dateTime":"2025-09-09T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK begins shipping influenza vaccine doses for the 2025-26 flu season in Canada","description":"GSK Canada (GlaxoSmithKline Inc.) today announced it has started shipping doses of its trivalent seasonal influenza vaccine","url":"/en-ca/media/press-releases/gsk-begins-shipping-influenza-vaccine-doses-for-the-2025-26-flu-season-in-canada/","datePublished":"September 08 2025","dateTime":"2025-09-08T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"Breaking the Silence on Gynaecological Cancers: Empowering Canadian Women to Take Action","description":"Canadian survey highlights gaps in awareness and urges proactive conversations on symptoms, risk factors and prevention strategies.","url":"/en-ca/media/press-releases/breaking-the-silence-on-gynaecological-cancers-empowering-canadian-women-to-take-action/","datePublished":"August 27 2025","dateTime":"2025-08-27T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma","description":"Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma","url":"/en-ca/media/press-releases/blenrep-belantamab-mafodotin-combinations-approved-in-canada-for-the-treatment-of-relapsedrefractory-multiple-myeloma/","datePublished":"July 23 2025","dateTime":"2025-07-23T12:00:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"Jemperli receives positive funding recommendations from CDA-AMC and INESSS in all adult patients with primary advanced or first recurrent endometrial cancer","description":"GSK is pleased to announce that Jemperli (dostarlimab for injection) has received positive reimbursement recommendations","url":"/en-ca/media/press-releases/jemperli-receives-positive-funding-recommendations-from-cda-amc-and-inesss-in-all-adult-patients-with-primary-advanced-or-first-recurrent-endometrial-cancer/","datePublished":"June 26 2025","dateTime":"2025-06-26T09:19:03","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK and Dalhousie University Collaborate to Address Health Equity Gaps through the GSK Vaccinology and Health Equity Fellowship Award","description":"Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been honoured as","url":"/en-ca/media/press-releases/gsk-and-dalhousie-university-collaborate-to-address-health-equity-gaps-through-the-gsk-vaccinology-and-health-equity-fellowship-award/","datePublished":"June 18 2025","dateTime":"2025-06-18T06:33:06","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"New real-world study reveals oral corticosteroid overuse in patients with chronic rhinosinusitis with nasal polyps","description":"A new Canadian real-world study, ACTIONS","url":"/en-ca/media/press-releases/new-real-world-study-reveals-oral-corticosteroid-overuse-in-patients-with-chronic-rhinosinusitis-with-nasal-polyps/","datePublished":"June 10 2025","dateTime":"2025-06-10T20:08:42","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo School of Pharmacy","description":"GSK is proud to announce a $300,000 investment in the Pharmacy Innovation in Immunization Research Collaborative (PIIRC)","url":"/en-ca/media/press-releases/gsk-invests-300-000-to-help-launch-the-pharmacy-innovation-in-immunization-research-collaborative-piirc-at-the-university-of-waterloo-school-of-pharmacy/","datePublished":"June 06 2025","dateTime":"2025-06-06T06:49:00","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]},{"headline":"GSK’s depemokimab accepted for review by Health Canada for the treatment of asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps","description":"GSK has submitted a New Drug Submission (NDS) to Health Canada for depemokimab","url":"/en-ca/media/press-releases/gsk-s-depemokimab-accepted-for-review-by-health-canada-for-the-treatment-of-asthma-with-type-2-inflammation-and-for-chronic-rhinosinusitis-with-nasal-polyps/","datePublished":"May 26 2025","dateTime":"2025-05-26T08:58:25","downloadUrl":null,"downloadAriaLabel":null,"downloadFileSize":null,"downloadExtension":null,"categories":["Canada"],"tags":[]}]},"captions":{"showMore":"Show more","mostRecent":"Most recent","mostRelevant":"Most relevant","search":"Search","download":"Download","resetSearch":"Reset search","clear":"Clear all","noResults":"We’re sorry, we can’t seem to find any search results matching your criteria.","resultsAvailable":null,"cancel":"Cancel","apply":"Apply","nowPlaying":null,"paginationAriaLabel":"Pagination","previous":"","previousAriaLabel":"Go to previous page","next":"next","nextAriaLabel":"Go to next page","goToPageAriaLabel":"Go to page ##PAGE##","currentPageAriaLabel":"Page","numberOfResultsPerPage":"Number of results per page","playVideo":"Play video {title}","filterBy":"Filter By:","sortBy":"Sort By:","select":"Select","category":"Category","dateRange":"Select date range","dateRangeBubbleText":"Date range","all":"All","lastWeek":"Last week","lastMonth":"Last month","lastSix":"Last 6 months","searchPrompt":"Enter a search term...","resultsText":"{filteredCount} out of {totalCount} results\n","tabbedArchivedSearchLabel":"","tabbedSearchBarLatestLabel":"","tabbedLatestTabDescription":"","tabbedVersionArchivedDescription":""},"id":6373,"docCheckLogout":null,"pageType":"pressReleaseListingPage","languageCode":"en-CA","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-ca/","openInNewWindowText":null},{"text":"Media","href":"/en-ca/media/","openInNewWindowText":null},{"text":"Press releases","href":"/en-ca/media/press-releases/","openInNewWindowText":null}]},"pageName":"Press releases","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-ca/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":false,"text":"Canada (EN/FR)"},"languageSelector":{"currentLanguage":"English","currentLanguageMobile":"EN","selectableLanguages":[{"opensInNewWindow":"Opens in a new window","desktopName":"English","mobileName":"EN","code":"/en-ca/","target":null},{"opensInNewWindow":"Opens in a new window","desktopName":"Français","mobileName":"FR","code":"/fr-ca/","target":null}]},"darkModeSwitch":{"text":"Dark Mode","tooltipText":"Switch to dark mode to head towards a more sustainable world together. More info.
"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"locationSelector":{"text":"Location selector","href":"/en-ca/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-ca/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-ca/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-ca/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"At a glance","url":"/en-ca/company/at-a-glance/","nodes":[],"isActive":false},{"title":"Canada leadership team","url":"/en-ca/company/canada-leadership-team/","nodes":[],"isActive":false},{"title":"Policies","url":"/en-ca/company/policies/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global Outstanding people","image":{"src":"/media/l20f4brn/navthumb-web09-header-gskh_2_2022_smtspc_37_hess.jpg?rxy=0.355,0.36888888888888888&width=329&height=185&format=webp&quality=100&v=1dbf19a8f7504b0","alt":"Man smiling during a meeting","darkModeSrc":"/media/l20f4brn/navthumb-web09-header-gskh_2_2022_smtspc_37_hess.jpg?rxy=0.355,0.36888888888888888&width=329&height=185&format=webp&quality=90&v=1dbf19a8f7504b0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/outstanding-people/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global policy positions","image":{"src":"/media/zx5kpb4m/gsk_texture_fluid_03_a_cmyk_web-size.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a9142e6e0","alt":"Orange texture","darkModeSrc":"/media/zx5kpb4m/gsk_texture_fluid_03_a_cmyk_web-size.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a9142e6e0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/policy-positions","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-ca/innovation/","nodes":[{"title":"Therapeutic areas","url":"/en-ca/innovation/therapeutic-areas/","nodes":[],"isActive":false},{"title":"Trials","url":"/en-ca/innovation/trials/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global pipeline","image":{"src":"/media/xskjorin/ware_3_2022_prodqc_14_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a91879100","alt":"Science experiment","darkModeSrc":"/media/xskjorin/ware_3_2022_prodqc_14_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a91879100"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/innovation/pipeline/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global Behind the science magazine","image":{"src":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a8b311970","alt":"3D rendering of immuno-oncology cells","darkModeSrc":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a8b311970"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/behind-the-science-magazine/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-ca/products/","nodes":[{"title":"Products A-Z","url":"/en-ca/products/products-a-z/","nodes":[],"isActive":false},{"title":"Stiefel - Dermatology","url":"/en-ca/products/stiefel-dermatology/","nodes":[],"isActive":false},{"title":"Report a possible side effect","url":"/en-ca/products/report-a-possible-side-effect/","nodes":[],"isActive":false},{"title":"Patient Support and Healthcare Support Services","url":"/en-ca/products/patient-support-and-healthcare-support-services/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Report a possible side effect","image":{"src":"/media/0otczyps/web03-header-stvg_2_2022_port_5_hess_nav.jpg?rxy=0.53,0.48444444444444446&width=329&height=185&format=webp&quality=100&v=1dbf19a8dba8370","alt":"Woman in a labcoat smiling at the camera","darkModeSrc":"/media/0otczyps/web03-header-stvg_2_2022_port_5_hess_nav.jpg?rxy=0.53,0.48444444444444446&width=329&height=185&format=webp&quality=90&v=1dbf19a8dba8370"},"link":{"text":"Featured section","href":"/en-ca/products/report-a-possible-side-effect/","openInNewWindowText":null}},{"text":"GSKPro","image":{"src":"/media/i5mft2xn/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?rxy=0.48,0.23555555555555555&width=329&height=185&format=webp&quality=100&v=1dbf19a8e994ab0","alt":"Two people hanging out together in front of an orange background","darkModeSrc":"/media/i5mft2xn/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?rxy=0.48,0.23555555555555555&width=329&height=185&format=webp&quality=90&v=1dbf19a8e994ab0"},"link":{"text":"Featured website","href":"https://gskpro.com/en-ca/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-ca/responsibility/","nodes":[{"title":"Inclusion","url":"/en-ca/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"Ethical standards","url":"/en-ca/responsibility/ethical-standards/","nodes":[{"title":"Engaging with healthcare professionals","url":"/en-ca/responsibility/ethical-standards/engaging-with-healthcare-professionals/","nodes":[],"isActive":false},{"title":"Transparency reporting","url":"/en-ca/responsibility/ethical-standards/transparency-reporting/","nodes":[],"isActive":false},{"title":"Medical grants","url":"/en-ca/responsibility/ethical-standards/medical-grants/","nodes":[],"isActive":false}],"isActive":false},{"title":"Charitable investments in Canada","url":"/en-ca/responsibility/charitable-investments-in-canada/","nodes":[],"isActive":false},{"title":"Accessibility","url":"/en-ca/responsibility/accessibility/","nodes":[{"title":"GSK’s Multi-Year Accessibility Plan","url":"/en-ca/responsibility/accessibility/gsk-s-multi-year-accessibility-plan/","nodes":[],"isActive":false}],"isActive":false},{"title":"Patient group funding","url":"/en-ca/responsibility/patient-group-funding/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Ethical standards","image":{"src":"/media/uxlkxzrj/ware_3_2022_prodqc_38_hess-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a8db07150","alt":"Group working together in a lab","darkModeSrc":"/media/uxlkxzrj/ware_3_2022_prodqc_38_hess-1.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a8db07150"},"link":{"text":"Featured section","href":"/en-ca/responsibility/ethical-standards/","openInNewWindowText":null}},{"text":"Global responsibility","image":{"src":"/media/olhgq5am/stvg_2_2022_smtlab_2_hess-1920x1080px.jpeg?rxy=0.41851106639839036,0.37764350453172207&width=329&height=185&format=webp&quality=100&v=1dbf19a8dc8db50","alt":"Man adjusting glasses working on a computer","darkModeSrc":"/media/olhgq5am/stvg_2_2022_smtlab_2_hess-1920x1080px.jpeg?rxy=0.41851106639839036,0.37764350453172207&width=329&height=185&format=webp&quality=90&v=1dbf19a8dc8db50"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/responsibility/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-ca/media/","nodes":[{"title":"Press releases","url":"/en-ca/media/press-releases/","nodes":[],"isActive":true},{"title":"Media contacts","url":"/en-ca/media/media-contacts/","nodes":[],"isActive":false},{"title":"Resource library","url":"/en-ca/media/resource-library/","nodes":[],"isActive":false}],"isActive":true,"promos":[{"text":"Global press releases","image":{"src":"/media/zyvhqfdo/gsk-house-view.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a9120dff0","alt":"Artwork in GSK Building","darkModeSrc":"/media/zyvhqfdo/gsk-house-view.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a9120dff0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/media/press-releases/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-ca/careers/","nodes":[{"title":"Life at GSK","url":"/en-ca/careers/life-at-gsk/","nodes":[],"isActive":false},{"title":"Experienced professionals","url":"/en-ca/careers/experienced-professionals/","nodes":[],"isActive":false},{"title":"Early careers","url":"/en-ca/careers/early-careers/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global how we hire","image":{"src":"/media/sbrno3h2/gsk_rix_24_10_18_p_d2_s4_064-how-we-hire-1920x960px.jpg?rxy=0.579476861167002,0.32661290322580644&width=329&height=185&format=webp&quality=100&v=1dbf19a8f7fb310","alt":"People talking together in a meeting","darkModeSrc":"/media/sbrno3h2/gsk_rix_24_10_18_p_d2_s4_064-how-we-hire-1920x960px.jpg?rxy=0.579476861167002,0.32661290322580644&width=329&height=185&format=webp&quality=90&v=1dbf19a8f7fb310"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/how-we-hire/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global future leaders program","image":{"src":"/media/vgal0nno/gskh-2-2022-smtspc-11-hess-future-leaders-graduate-programme-1920x960px.jpg?rxy=0.42655935613682094,0.3911290322580645&width=329&height=185&format=webp&quality=100&v=1dbf19a8f2d4d50","alt":"Two people conversing together in an office","darkModeSrc":"/media/vgal0nno/gskh-2-2022-smtspc-11-hess-future-leaders-graduate-programme-1920x960px.jpg?rxy=0.42655935613682094,0.3911290322580645&width=329&height=185&format=webp&quality=90&v=1dbf19a8f2d4d50"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme","target":"_blank","openInNewWindowText":"Opens in a new window"}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=5769","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-ca/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"This website is intended for visitors looking for information on GSK Canada. Other market sites can be reached by visiting our location selector.
\n© 2001-2026 GSK plc. All rights reserved. Trademarks are owned by or licensed to the GSK group of companies.
\nGSK plc. Registered in England and Wales No. 3888792.
\nGlaxoSmithKline Inc. 100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1
","modernSlaveryStatement":{"name":"GSK Modern Slavery Act Statement 2023","url":"/media/iwinetmy/modern-slavery-act-statement-2023.pdf","fileExtension":"PDF","fileSize":"154.2KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window"},"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"https://twitter.com/gskca","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on X","customIcon":null,"showPopupMenu":false,"type":"X"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Facebook","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Youtube","customIcon":null,"showPopupMenu":false,"type":"Youtube"},{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on LinkedIn","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gsk/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"GSK Global website","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Market website selector","href":"/en-ca/locations/","openInNewWindowText":null},{"text":"Global Behind the science magazine","href":"https://www.gsk.com/en-gb/behind-the-science/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSKPro for healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK Medical for healthcare professionals","href":"https://medical.gsk.com/en-ca/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/en-ca/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Supplier website","href":"https://supplier.gsk.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Company","href":"/en-ca/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-ca/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-ca/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-ca/responsibility/","openInNewWindowText":null},{"text":"Media","href":"/en-ca/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-ca/careers/","openInNewWindowText":null}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-ca/contact-us/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-ca/products/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-ca/responsibility/accessibility/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Terms of use","href":"/en-ca/terms-of-use/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Cookie policy","href":"/en-ca/cookie-policy/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-ca/privacy-notice/general/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-ca/sitemap/","openInNewWindowText":null}],"continueToLink":{"text":"Media contacts","href":"/en-ca/media/media-contacts/","openInNewWindowText":null,"continueTo":""},"legalApprovalText":""},"sharing":{"description":"Keep up to date with our news and recent announcements","og":[{"property":"og:title","content":"Press releases"},{"property":"og:description","content":"Keep up to date with our news and recent announcements"},{"property":"og:image","content":"https://ca.gsk.com/media/m0ffxymm/gskh_3_2022_comspc_19_hess.jpg?rxy=0.41046277665995978,0.35347432024169184&width=600&format=webp&quality=100&v=1dbf19a8f3897f0"},{"property":"og:url","content":"https://ca.gsk.com/en-ca/media/press-releases/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"Press releases"},{"name":"twitter:description","content":"Keep up to date with our news and recent announcements"},{"name":"twitter:image","content":"https://ca.gsk.com/media/m0ffxymm/gskh_3_2022_comspc_19_hess.jpg?rxy=0.41046277665995978,0.35347432024169184&width=600&format=webp&quality=100&v=1dbf19a8f3897f0"},{"name":"twitter:url","content":"https://ca.gsk.com/en-ca/media/press-releases"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":true,"title":"You are leaving our website","texts":"The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.
","continueText":"Continue","cancelText":"Cancel","exclusionUrls":["http://gsk.com/","https://www.gsk.com","https://innovation.gsk.com/","https://www.gskgrants.com","https://www.gskforyou.com/","https://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","http://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","https://www.gsk.com/en-gb/products/stiefel-dermatology/","https://www.gsk.com/en-gb/products/viiv-healthcare/","https://www.contactus.gsk.com/callback/index.html","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsksource.com/pharma/content/gsk/source/us/en.html","http://www.msds-gsk.com/","https://www.gsk.com/en-gb/investors/shareholder-information/","http://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/investors/corporate-reporting/","https://www.gsk.com/en-gb/investors/product-pipeline/","http://www.gskgrants.com/","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsk.com/media/2941/human-rights-statement-policy.pdf","http://www.gsk.com/media/280848/human-rights-statement-policy.pdf","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","http://twitter.com/GSK","http://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/media/press-releases/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-impact-and-appropriate-use-of-corticosteroids-in-sle-management/","http://www.gskforyou.com/","https://www.gskforyou.com/prescription-resource-assistance/immunology-respiratory/","https://www.contactus.gsk.com/callback.html","https://www.gsk.com/en-gb/about-us/governance/global-compliance/","https://www.gsk.com/en-gb/careers/physicians/","https://www.gsk.com/en-gb/contact-us/worldwide/","https://access.gsk.com/password/","https://access.gsk.com/selfservice/static/login.jsp?TYPE=33554433&REALMOID=06-c7edf5ec-5585-100d-83b1-84797f88fc89&GUID=&SMAUTHREASON=0&METHOD=GET&SMAGENTNAME=-SM-90R5K5a0NsTyKRhPyTIn3A3B5ovKkqcehflGRUrUNusjZdRaPY%2bWUozEFizs1bMg&TARGET=-SM-https%3a%2f%2fuksah%2egsk%2ecom%2fswh_uk_win_ns%2fcommunications%2femployee%2femployees%2ehtm","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://ascend.cvmsolutions.com/Account/Login?client=gsk","https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf","https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/","https://www.gsk.com/media/2538/gsk-materiality-process.pdf","https://www.gsk.com/en-gb/responsibility/access-to-healthcare/","https://www.gsk.com/en-gb/responsibility/our-people/","https://www.gsk.com/en-gb/responsibility/environment/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/","https://www.gsk.com/media/4552/our-code-of-practice.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=10","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/en-gb/media/resource-centre/","https://www.gsk.com/en-gb/media/image-and-video-library/","https://www.gsk.com/en-gb/media/rss-feeds/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf","https://www.gsk.com/en-gb/careers/meet-our-people/","https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/","https://gskearlytalent.avature.net/landingpage","https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","https://www.gsk.com/en-gb/research/our-approach/open-innovation/","https://www.youtube.com/channel/UChWuz9ZDceHYHXmJVJ4hF8Q","https://www.youtube.com/channel/UCN1XeWQWLVhFLHQwZl93jFQ","https://www.youtube.com/channel/UCwQyIfV4pLlsZGuN7fiZm2w","https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/","https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","http://uk.gsk.com/en-gb/careers/apprenticeships/","https://www.gsk.com/media/4931/gsk-quick-facts.pdf","https://ie.gsk.com/ie/careers/apprenticeships/","http://au.gsk.com/en-au/careers/apprenticeships/","http://sg.gsk.com/en-sg/careers/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/","https://gsk.i-sight.com/landing-page/","https://www.gskforyou.com/","https://privacy.gsk.com/en-ca/privacy-notice/general","http://annualreport.gsk.com/","https://privacy.gsk.com","https://www.gsk.com/en-gb/company/outstanding-people/","https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-fy-2021-reported-sales-of-34-billion-stable-at-aer-plus5-cer/","https://www.gsk.com/media/7473/esg-performance-report-2021.pdf","https://www.gsk.com/en-gb/behind-the-science/","https://gskpro.com/","https://viivhealthcare.com/","https://gsk.supplierone.co/","https://www.gsk.com/speakup","https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/","https://www.gsk.com/en-gb/research-and-development/our-approach-to-rd/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/en-gb/company/policy-positions","https://www.gsk.com/en-gb/company/codes-standards-and-reports","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/en-gb/innovation/rd-locations/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk-studyregister.com","https://gskpro.com/en-ca/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/diversity-equity-and-inclusion/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://annualreport.gsk.com/","https://www.gsk.com/en-gb/media/media-contacts/","https://www.gsk.com/en-gb/media/media-library/","https://www.gsk.com/en-gb/media/social-media/","https://www.gsk.com/en-gb/media/our-response-to-the-situation-in-ukraine/","https://www.gsk.com/en-gb/careers/featured-careers/","https://www.gsk.com/en-gb/careers/how-we-hire/","https://www.gsk.com/en-gb/careers/our-global-and-regional-hubs/","https://www.gsk.com/en-gb/careers/how-we-hire/frequently-asked-questions/","https://www.gsk.com/en-gb/careers/","https://www.gsk.com/en-gb/careers/early-talent/kickstart-your-career/","https://www.gsk.com/en-gb/careers/early-talent/apprentice-programmes/","https://www.gsk.com/en-gb/careers/early-talent/work-experience-placements-and-internships/","https://www.gsk.com/en-gb/company/governance/compliance/","https://gskpro.com","https://www.gsk-studyregister.com/","https://www.gsk.com/en-gb/company/gsk-at-a-glance/","https://www.gsk.com/en-gb/innovation/technologies/","https://www.gsk.com/en-gb/innovation/trials/diversity-in-clinical-trials/","https://www.gsk.com/en-gb/responsibility/","https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme","https://privacy.gsk.com/en-ca/privacy-notice/","https://us.gsk.com/en-us/about-us/us-community-partnerships/stem-education/philadelphia-stem-equity-collective/","https://www.gsk.com/en-gb/responsibility/charitable-partnerships/","https://supplier.gsk.com/irj/portal/public","https://privacy.gsk.com/en-ca/privacy-notice/general/","https://twitter.com/gskca","https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-2022-performance-with-full-year-sales-of-293-billion/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/respiratoryimmunology/","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2023/","https://www.gsk.com/en-gb/responsibility/environment/climate/","https://supplier.gsk.com/"]},"settings":{"optionalStylesheetLink":"/media/bbcob5qx/optional_style_ca.css","themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://ca.gsk.com/media/s3hkylbc/gsk-logo_png.png?width=104&format=webp&quality=100&v=1dbf19a937d1f70","alt":"Gsk Logo Png","darkModeSrc":"https://ca.gsk.com/media/s3hkylbc/gsk-logo_png.png?width=104&format=webp&quality=90&v=1dbf19a937d1f70"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK Canada"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://ca.gsk.com/en-ca/media/press-releases/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null,"modules":[{"type":"varied-signpost-grid","title":"You might also like","layoutPattern":4,"pages":[{"title":"At a glance","content":"Getting Ahead Together means preventing disease as well as treating it","image":{"src":"/media/2c0loaov/gsk_rix_24_10_18_p_d2_s1_128_re-sized.jpg?width=427&height=533&format=webp&quality=100&v=1dbf19a8ddcb170","alt":"Man in laboratory setting inspecting a blue vial","darkModeSrc":"/media/2c0loaov/gsk_rix_24_10_18_p_d2_s1_128_re-sized.jpg?width=427&height=533&format=webp&quality=90&v=1dbf19a8ddcb170"},"link":{"text":"At a glance","href":"/en-ca/company/at-a-glance/","openInNewWindowText":null}},{"title":"Canada leadership team","content":"The Leadership Team encompasses the Country Executive Board (CEB) and is responsible for the management of the business","image":{"src":"/media/r1ccwsbf/71c087b1-1337-46ea-97c9-9de0592f61af.jpg?width=427&height=533&format=webp&quality=100&v=1dbf19a9018e5d0","alt":"Portrait of Sridhar Venkatesh","darkModeSrc":"/media/r1ccwsbf/71c087b1-1337-46ea-97c9-9de0592f61af.jpg?width=427&height=533&format=webp&quality=90&v=1dbf19a9018e5d0"},"link":{"text":"Canada leadership team","href":"/en-ca/company/canada-leadership-team/","openInNewWindowText":null}},{"title":"Company","content":"We unite science, technology and talent to get ahead of disease together","image":{"src":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=427&height=533&format=webp&quality=100&v=1dbf19a8b311970","alt":"3D rendering of immuno-oncology cells","darkModeSrc":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=427&height=533&format=webp&quality=90&v=1dbf19a8b311970"},"link":{"text":"Company","href":"/en-ca/company/","openInNewWindowText":null}}],"hidePageDescription":false,"useGreyBackground":false}]}